Saturday, July 25, 2026

pharma · Dravet syndrome · Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)

Biocodex

Biocodex patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Gentilly, FR HQ
1953 Founded
1,648 Employees
EMA registrant Type
Company details
Status
Public
HQ
Gentilly, FR
Founded
1953
Employees
1,648
Programs
0
Drugs
4
Patents
2
Intelligence · Patents

Biocodex patents

2 pharmaceutical patents indexed for Biocodex. 0 expire within 24 months.

Biocodex has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2026013310

    COMPOSITION PHARMACEUTIQUE LIQUIDE À BASE DE STIRIPENTOL

    Expires Wed Jan 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. EP 2875810

    Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung

    Expires Tue May 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Biocodex have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Biocodex patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.